The CYP4V2 gene gives your cells instructions for an enzyme that helps break down certain fats, especially in the retina, the light sensing tissue at the back of the eye. If this gene does not work properly, fatty material can build up and slowly harm retinal cells. Pathogenic variants in the CYP4V2 gene are a known cause of Bietti crystalline dystrophy, an inherited eye condition that can lead to trouble seeing at night, blind spots, and gradual vision loss.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells can use to make molecules or regulate processes in the body. Some genes give the directions for making proteins, the parts of cells that do much of the work. Other genes mainly help determine when certain processes happen, where they happen, and how strongly they run. Taken together, genes influence how the body develops and functions, and they can affect how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
CYP4V2Gene function
What if the gene works
The CYP4V2 gene helps cells process certain fats. This is especially important in the retina, where its enzyme supports normal lipid balance and eye tissue health.
Risk
What if the gene does not work
Variants in the CYP4V2 gene can cause Bietti crystalline dystrophy, an inherited eye condition that affects the retina and can lead to gradually worsening vision. Milder and more severe variants may influence when symptoms begin and how fast vision changes progress.
Treatment
What does that mean for your treatment
No treatment or drug selection approach specific to pathogenic or loss-of-function variants in the CYP4V2 gene is currently established. The CYP4V2 gene is being studied in early retinal gene therapy research, but this has not yet changed routine care.
Conditions associated with CYP4V2
Gene function
What if the gene works
Your cells use the CYP4V2 gene to handle certain fats, especially in the eye. It helps process long chain fatty acids so they can be reshaped, reused, or cleared in a controlled way. This steady fat control supports the retina, which depends on a healthy balance of oils to work smoothly.
The CYP4V2 gene helps cells process certain long chain fatty acids. Its protein places oxygen onto these fats, a common first step that helps the body reshape or clear them.
In the retina, this gene helps keep the right balance of fats around light sensing cells and their support layer. This steady work explains much of CYP4V2 gene function in the retina.
By helping manage fatty acids, CYP4V2 supports the normal makeup of cell membranes, the thin outer covering of cells. This matters in tissues that use and recycle fats every day.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and contribute to normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply reflect natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CYP4V2 gene can alter the enzyme’s shape, stability, or activity, so cells handle certain fats less effectively. Some changes only partly reduce function, while more disruptive variants may prevent the enzyme from working at all. This range helps explain why the functional effect of CYP4V2 gene variants in Bietti crystalline dystrophy can differ, and why symptoms may begin earlier or progress differently in some people.
How variants are linked to conditions
Pathogenic variants in the CYP4V2 gene cause Bietti crystalline dystrophy, an inherited eye condition that often brings night vision trouble, blind spots, and gradual loss of side and central vision. In discussions of the CYP4V2 gene and Bietti crystalline dystrophy, this may also be called Bietti crystalline corneoretinal dystrophy. Reported cases are more common in East Asian populations, though the condition can affect people of many backgrounds.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CYP4V2, risk is mainly determined by genetics: people usually develop related eye disease only if they inherit two changed copies of the gene, one from each parent. There is not broadly confirmed evidence that lifestyle or environmental factors meaningfully change this inherited risk, so people concerned about family risk should speak with a doctor or genetic counselor.
Inheritance of CYP4V2 variants
Variants in the CYP4V2 gene are inherited in an autosomal recessive pattern. This means a person usually develops CYP4V2-related disease only when they inherit two altered copies, one from each parent. Parents who each carry one variant are typically unaffected carriers, and with each pregnancy there is a 25% chance their child will inherit both variants, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. In practical terms, how variants of the CYP4V2 gene are inherited often becomes clear when an affected child is born to two healthy carrier parents.
What does my CYP4V2 result mean for my family?
For CYP4V2, family impact is usually discussed in terms of a recessive inherited eye condition. Close relatives may also carry the same gene change, and brothers or sisters can sometimes have the condition or be carriers even if they have no symptoms. A CYP4V2 result can be especially relevant for family planning, because a child is more likely to be affected when both parents carry a changed copy.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for CYP4V2 variants uses a blood or saliva sample to read the CYP4V2 gene and look for changes in the DNA code. It can show whether you carry one or two variants linked to inherited retinal disease and may help confirm the genetic cause of symptoms or family history.
When should I consider getting a genetic test?
Consider genetic testing for the CYP4V2 gene if you or a family member has signs of Bietti crystalline dystrophy, an inherited eye condition that can cause night vision problems, blind spots, or gradually worsening sight. Testing can help confirm the cause and clarify whether close relatives may also carry the gene change.
A genetic result is only one part of your health story
A genetic result can be helpful, but how much it explains varies by the condition and the kind of variant involved. Over time, the way the body works is also shaped by factors such as age, environment, lifestyle, and medical history. For some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in your DNA can change how your body breaks down, moves, or responds to a drug, so the same treatment may work better for one person than for another. This is a common reason some people get more benefit, while others notice less effect or are more sensitive to side effects. Genetics is only one part of the picture, but it can play an important role in medication response.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape the way people respond to medications. It studies links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how the body processes a drug and how strong its effects are. This information can support more informed, individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the CYP4V2 gene
When should I seek medical advice?
There is not yet strong, widely accepted evidence that this gene should be used to guide medicine choices, so questions about side effects, new symptoms, or treatment changes are best discussed with your doctor.
History
CYP4V2 entered the medical literature through research on Bietti crystalline dystrophy, a rare inherited eye condition first described by the Italian ophthalmologist Gian Battista Bietti in 1937. For decades, doctors recognized the pattern in affected families before the genetic cause was clear. From these first observations, research expanded steadily, and in 2004 researchers linked pathogenic variants in the CYP4V2 gene to the condition. That finding gave families a clearer explanation for the diagnosis and helped connect clinical eye findings with molecular genetics. Since then, studies in different populations have identified many CYP4V2 variants and refined how this gene is used in inherited retinal disease testing.